BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8868284)

  • 1. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver.
    Arano Y; Mukai T; Akizawa H; Uezono T; Motonari H; Wakisaka K; Kairiyama C; Yokoyama A
    Nucl Med Biol; 1995 Jul; 22(5):555-64. PubMed ID: 7581163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
    J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody.
    Arano Y; Inoue T; Mukai T; Wakisaka K; Sakahara H; Konishi J; Yokoyama A
    J Nucl Med; 1994 Feb; 35(2):326-33. PubMed ID: 8295006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
    Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
    Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.
    Kobayashi H; Sato N; Saga T; Nakamoto Y; Ishimori T; Toyama S; Togashi K; Konishi J; Brechbiel MW
    Eur J Nucl Med; 2000 Sep; 27(9):1334-9. PubMed ID: 11007515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
    Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
    J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
    Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
    Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
    Schuhmacher J; Klivényi G; Hull WE; Matys R; Hauser H; Kalthoff H; Schmiegel WH; Maier-Borst W; Matzku S
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):809-24. PubMed ID: 1428911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
    Sun B
    Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
    Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
    Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with ⁹⁰Y and ¹¹¹In for domestic radioimmunotherapy and radioscintigraphy of non-Hodgkin's lymphoma.
    Gholipour N; Jalilian AR; Khalaj A; Johari-Daha F; Yavari K; Sabzevari O; Khanchi AR; Akhlaghi M
    Daru; 2014 Jul; 22(1):58. PubMed ID: 25074720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymatic digestion in vitro and in vivo.
    Studer M; Kroger LA; DeNardo SJ; Kukis DL; Meares CF
    Bioconjug Chem; 1992; 3(5):424-9. PubMed ID: 1420442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
    Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
    Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.